Pharmaceutical Executive

Pharmaceutical Executive Podcast
  • ٠٫٠ (٠)
  • علوم حياة
  • يتم التحديث يوميًا

The Pharm Exec Podcast goes beyond the pages of the Pharmaceutical Executive print magazine and PharmExec.com to bring the latest commercial insights to the C-suite through in-depth interviews. Podcast episodes examine current trends, key conferences, and critical topics in the industry. 

  1. Pharmaceutical Executive Daily: Idvynso Receives FDA Approval

    قبل ٦ ساعات

    Pharmaceutical Executive Daily: Idvynso Receives FDA Approval

    In today’s Pharmaceutical Executive Daily, the FDA approves a new treatment for HIV-1 infection in adults, Amazon One Medical launches a GLP-1 weight management program, and a new report highlights which top-selling drugs are most at risk of supply shortages.

    **ASE.Web.Podcasts.Duration.Minute.two**
  2. Pharmaceutical Executive Daily: UnitedHealth Raises Full-Year Profit Forecast

    قبل يوم واحد

    Pharmaceutical Executive Daily: UnitedHealth Raises Full-Year Profit Forecast

    In today’s Pharmaceutical Executive Daily, UnitedHealth raises its full-year profit forecast following stronger-than-expected first-quarter results, Pfizer works to reshape its leadership narrative as it approaches a major patent cliff, and a new industry perspective highlights why scaling artificial intelligence in pharma requires more than just advanced algorithms.

    **ASE.Web.Podcasts.Duration.Minute.two**
  3. Pharmaceutical Executive Daily: Eli Lilly Acquires Kelonia Therapeutics

    قبل يومين

    Pharmaceutical Executive Daily: Eli Lilly Acquires Kelonia Therapeutics

    In today’s Pharmaceutical Executive Daily, Eli Lilly enters a $7 billion agreement to acquire Kelonia Therapeutics, the Trump administration issues an executive order to accelerate FDA reviews of psychedelic therapies, and Lilly’s oral weight loss pill sees strong early prescribing demand.

    **ASE.Web.Podcasts.Duration.Minute.two**
  4. Inside Pharma's Revenue Engine: The Gross-to-Net Reckoning

    قبل ٥ أيام

    Inside Pharma's Revenue Engine: The Gross-to-Net Reckoning

    In the debut episode of Pricing & Policy with Model N — a new podcast series from Pharmaceutical Executive — Model N VP of product management Michael Grosberg joins host Mike Christel to break down what the company's annual state of revenue survey reveals about the mounting pressures threatening pharma's commercial foundation. From PBM opacity and Medicaid withdrawal to "ghost claims" lurking inside DTC channels, this conversation pulls back the curtain on the industry's most consequential — and perhaps least understood — business challenge: revenue management. 01:50 - Drivers of rising GTN complexity. 05:08 - The Medicaid dilemma: Exiting the program. 08:30 - Coordination of benefits and rebate eligibility: “We’re doing a really poor job at this.” 10:57 - The easiest way to solve the problem.  12:04 - IRA’s Medicare drug price negotiations: Where we stand. 16:20 - Launch strategy and sequencing considerations. 20:13 - MFN agreements transparency.  21:51 - Data disconnect blurs pricing and revenue visibility. 24:05 - AI "catch-up" imperatives for revenue management. 27:48 - System strain? DTC’s downstream impacts. 33:36 - Top threats to future model.

    ٣٧ د
  5. Pharmaceutical Executive Daily: Eli Lilly Releases Updated Safety Data for Foundayo

    قبل ٦ أيام

    Pharmaceutical Executive Daily: Eli Lilly Releases Updated Safety Data for Foundayo

    In today's Pharmaceutical Executive Daily, Eli Lilly releases updated safety data for its oral obesity pill Foundayo in response to an FDA post-approval request, ICER and Verdant Research publish a new white paper examining the evolution and future of the FDA's accelerated approval pathway, and a new Pharmaceutical Executive commentary argues FDA's shift toward single-trial approval standards marks the beginning of a genuinely new era in data-driven drug development.

    ٣ د
  6. Pharmaceutical Executive Daily: Obsidian and Galera Therapeutics Enter Merger Agreement

    ١٥ أبريل

    Pharmaceutical Executive Daily: Obsidian and Galera Therapeutics Enter Merger Agreement

    In today’s Pharmaceutical Executive Daily, platform innovation continues to drive biotech investment across oncology and immunology, Obsidian Therapeutics and Galera Therapeutics enter a $350 million merger agreement, and industry leaders explore a new standard for copay program excellence.

    **ASE.Web.Podcasts.Duration.Minute.two**
  7. Pharmaceutical Executive Daily: AbbVie and Haisco Enter $745 Million Licensing Agreement

    ١٤ أبريل

    Pharmaceutical Executive Daily: AbbVie and Haisco Enter $745 Million Licensing Agreement

    In today's Pharmaceutical Executive Daily, AbbVie licenses a portfolio of pain compounds from China's Haisco Pharmaceutical in a deal worth up to $745 million, the FDA grants full approval to Filspari as the first and only approved treatment for focal segmental glomerulosclerosis, and Pharmaceutical Executive speaks with Deepak Prakash of Identiv on how RFID and real-time tracking are building operational visibility in clinical trials.

    ٣ د
  8. Pharmaceutical Executive Daily: FDA Issues Second CRL for Replimune's RP1 Melanoma Treatment

    ١٣ أبريل

    Pharmaceutical Executive Daily: FDA Issues Second CRL for Replimune's RP1 Melanoma Treatment

    In today's Pharmaceutical Executive Daily, the FDA issues a second complete response letter for Replimune's RP1 in advanced melanoma, Regeneron and Telix Pharmaceuticals announce a radiopharmaceutical collaboration worth up to $2.1 billion, and Pharmaceutical Executive speaks with Matt Holms of Citeline on improving patient experience and real-world evidence integration in clinical trials.

    ٣ د
مشاهدة الكل (٣٣٨)

حول

The Pharm Exec Podcast goes beyond the pages of the Pharmaceutical Executive print magazine and PharmExec.com to bring the latest commercial insights to the C-suite through in-depth interviews. Podcast episodes examine current trends, key conferences, and critical topics in the industry. 

المعلومات

  • صناع العمل
    Pharmaceutical Executive Podcast
  • سنوات النشاط
    ٢٠١٨ - ٢٠٢٦
  • الحلقات
    ٣٣٨
  • التقييم
    ملائم
  • موقع البرنامج على الويب
    Pharmaceutical Executive

قد يعجبك أيضًا